AZD2014 50mg 50mg | Purity Not Available
Adooq Bioscience
AZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor.
More Information Supplier PageAZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor.
More Information Supplier PageAZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor.
More Information Supplier PageAZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor.
More Information Supplier PageAzafen is a tricyclic antidepressant.It acts as a potent inhibitor of the reuptake of serotonin.
More Information Supplier PageAzafen is a tricyclic antidepressant.It acts as a potent inhibitor of the reuptake of serotonin.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAMG-073 (Cinacalcet) represents a new class of compounds for the treatment of hyperparathyroidism.
More Information Supplier PageAT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
More Information Supplier Page